The AKR1C3-Activated Prodrug, Achm-025, Eradicates Disease in Preclinical Models of Aggressive T-Cell Acute Lymphoblastic LeukemiaRichard B. Lock,Cara E. Toscan,Hannah McCalmont,Kathryn Evans,Louise Doculara,Hansen J. Kosasih,Andrew J. Gifford,Amir Ashoorzadeh,Xiaojing Lin,Toby N. Trahair,Charles E. De Bock,Adam V. Patterson,Jeff B. SmaillBLOOD(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要